|
|
|
| Correlation Analysis of Serum SOD, NOX4 and ox-LDL Levels with Coronary Lesions in Patients with Coronary Heart Disease |
| SUN Li, WANG Ying-zhong |
| Yan'an Hospital of Traditional Chinese Medicine, Yan'an 716000 |
|
|
|
|
Abstract 【Objective】 To investigate the level and significance of superoxide dismutase (SOD), nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) and oxidized low density lipoprotein (ox-LDL) in patients with coronary heart disease. 【Methods】 From May 2017 to may 2018, 84 patients with coronary heart disease were selected, including 39 patients with acute coronary syndrome (ACS group), 45 patients with stable angina pectoris (SAP group) and 50 healthy volunteers as the control group. The levels of ox-LDL, SOD and NOX4 were compared in each group. The coronary stenosis was scored by Gensini method. The correlation between the levels of ox-LDL, SOD and NOX4 and Gensini score was analyzed. 【Results】 The serum SOD level of the ACS group and the SAP group was significantly lower than that of the control group, and the serum NOX4 and ox LDL levels were significantly higher than that of the control group (P<0.05); the serum SOD level of the ACS group was significantly lower than that of the SAP group, and the serum NOX4 and ox-LDL levels were significantly higher than that of the SAP group (P<0.05). The Gensini score of the ACS group was (38.16±3.70), which was significantly higher than that of the SAP group (30.41±4.64). The difference was statistically significant (t=-8.374, P<0.05). There was a negative correlation between SOD and Gensini score (r= -0.354, P<0.05), and a positive correlation between NOx 4, ox-LDL and Gensini score (r=0.322, 0.315, P<0.05).【Conclusion】 The serum SOD level of patients with coronary heart disease decreased significantly, while the serum NOX4、ox-LDL level increased significantly, and the serum SOD、NOX4、ox-LDL level was closely related to the Gensini score of patients with coronary heart disease.
|
|
Received: 04 December 2018
|
|
|
|
|
|
[1] Qiao Y, Zhang J, Liu Y, et al. Efficacy and safety of zhenyuan capsule for coronary heart disease with abnormal glucose and lipid metabolism: study protocol for a randomized, double-blind, parallel-controlled, multicenter clinical trial[J].Evid Based Complement Alternat Med,2018,28(5):1-7.
[2] 梁伟,赵雅洁,崔佩菁,等. 氧化应激系统对冠心病患者肾功能的影响[J].中华老年心脑血管病杂志,2015,17(5):482-484.
[3] 吕行直,李瑞芳,罗雪婷,等. 川穹嗪对肾性高血压大鼠左心室肥厚和还原型烟酰胺腺嘌呤二核苷酸磷酸氧化酶的影响[J].中国临床药理学杂志,2017,33(06):513-517.
[4] 何跃娥,诸凤,李萍,等. 氧化型低密度脂蛋白在早期预测川崎病冠状动脉损害中的价值[J].中华风湿病学杂志,2017,21(7):439-443.
[5] Houston M. The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease[J].Ther Adv Cardiovasc Dis,2018,12(3):85-108.
[6] 卢小岚,张晓,朱记法,等. 血β2-MG、CysC、SOD水平与冠状动脉血管病变的关系[J].中国实用医刊,2017,12(9):20-23.
[7] 蒋萍,李丽敏,顾彬,等. 上海松江地区汉族人群NAD(P)H氧化酶C242T基因多态性与高脂血症及脑梗死的相关性研究[J].中华神经医学杂志,2016,15(2):164-171.
[8] 章春艳,曹政. 氧化型低密度脂蛋白对急性冠状动脉综合征患者血小板聚集率的影响[J].中国动脉硬化杂志,2016,24(5):485-489.
[9] 李红卫,黄玉凤,王新芳,等. 多种血液指标在冠心病患者临床检测中的应用价值[J].中国卫生检验杂志,2016,26(5):616-618.
[10] 付红,周大亮,管永斌,等. 冠状动脉粥样硬化早期诊断生物标志物的代谢组学研究进展[J].中华老年心脑血管病杂志,2017,19(12):1327-1328. |
|
|
|
2020, Vol. 37 
